Ceribell, Inc. (NASDAQ:CBLL)
| Market Cap | $1.06B+71.1% |
| Revenue (ttm) | $108.72M+31.3% |
| Net Income | -$73.88M-40.8% |
| EPS | -$1.94-28.5% |
| Shares Out | 38.84M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 655,968 |
| Open | $25.83 |
| Previous Close | $25.75 |
| Day's Range | $25.83 - $27.43 |
| 52-Week Range | $14.87 - $28.89 |
| Beta | 0.86 |
| Analysts | Buy |
| Price Target | $27.50(+0.40%) |
| Earnings Date | Feb 23, 2027 |
About CBLL
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Ceribell, Inc. Stock Analysis — InsiderScore
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
3 firms rating CBLL in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 23, 2027Earnings report
$CBLL stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CBLL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CBLL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CBLL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CBLL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CBLL from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CBLL
| VTIVanguard Morningstar Total Stock Market ETF | $21.71M |
| IWMiShares Russell 2000 ETF | $20.41M |
| VXFVanguard Extended Market ETF | $7.71M |
| IWOiShares Russell 2000 Growth ETF | $6.76M |
| VTWOVanguard Russell 2000 ETF | $4.31M |
| IHIiShares U.S. Medical Devices ETF | $3.49M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CBLL’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
-39.0 since Aug 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| LFSC | F/M Emerald Life Sciences Innovation ETF | 1.99% |
| IBRN | iShares Neuroscience and Healthcare ETF | 1.00% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 0.96% |
| WCEO | Hypatia Women CEO ETF | 0.48% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 0.21% |
| IWC | iShares Micro-Cap ETF | 0.19% |
| FFSM | Fidelity Fundamental Small-Mid Cap ETF | 0.15% |
| FSMO | Fidelity Fundamental Small-Mid Cap ETF | 0.15% |
| IHI | iShares U.S. Medical Devices ETF | 0.09% |
| IWO | iShares Russell 2000 Growth ETF | 0.05% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.04% |
| VHT | Vanguard Health Care ETF | 0.01% |
Weight is the stock’s share of each fund’s holdings.
